New Drug Hope For PE Sufferers

There maybe hope for men who suffer from Premature Ejaculation, according to pharmaceutical company Johnson and Johnson who are currently seeking approval for their revolutionary drug therapy for this condition. Dapoxetine, originally developed by Eli Lilly and Co, is a short acting SSRI drug which will be entering the final stages of approval later this year. 

 

Researches at the University of Minnesota, who have lead a trial of the new treatment on 2,600 men effected by Premature Ejaculation, have found that Dapoxetine is capable of increasing the duration of sex for sufferers of the condition by up to three times. News of these findings will be greatly received by the estimated third of the male population effected.

 

The study, led by Dr Jon Pryor and his team, combined results from two separate trials – one using a 30mg dose of the drug and the other a 60mg dose. At the commencement of the study participants averaged just under a minute before they would ejaculate during sexual intercourse, over the 12 week trial this increased to three minutes and nineteen seconds.

 

When asked to comment on the conclusions of this study Dr Pryor said “Dapoxetine also improved patients’ perceptions of control over ejaculation, satisfaction with sexual intercourse, and overall impression of change in condition. Partners benefited through improved satisfaction with sexual intercourse.”

One Response to “New Drug Hope For PE Sufferers”

  1. Mo Says:

    Rather than using a drug, I wonder if there isn’t a homeopathic answer to this problem. Have you checked this method out? It seems to me that I remember a topical cream that PE sufferers would use to desensitize their penis. Just a thought.

Leave a Reply